Nosocomial pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU

Chest

Volumn 122, Issue 6, 2002, Pages 2183-2196

  Höffken, Gert ^a   Niederman, Michael S ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

De escalating antibiotic strategy; ICU; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CRITICAL ILLNESS; DEVICE INFECTION; DISEASE SEVERITY; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROFLORA; MICROORGANISM; MORTALITY; PATHOGENESIS; PHYSICIAN; PHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; VENTILATOR;

EID: 0036924312     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6.2183     Document Type: Review

References (87)

1. American Thoracic Society. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies; a consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153:1711-1725
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee. JAMA 1995; 274:639-644
3. Spencer RC. Epidemiology of infections in ICUs. Intensive Care Med 1994; 20(suppl):S2-S6
4. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-532
5. Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia: Attributable mortality and morbidity. Am J Epidemiol 1989; 129:1258-1267
6. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 1998; 158:1839-1847
7. Chevret S, Hemmer M, Carlet J, et al. Incidence and risk factors of pneumonia acquired in intensive care units: Results from a multicenter prospective study on 996 patients; European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19:256-264
8. Torres A, Anzar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528
9. Langer M, Mosconi P, Cigada M, et al. Long-term respiratory support and risk of pneumonia in critically ill patients: Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 1989; 140:302-305
10. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-884
11. Chastre J, Fagon JY, Domart Y, et al. Diagnosis of nosocomial pneumonia in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1989; 8:35-39
12. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-440
13. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
14. Fagon J-Y, Chastre, J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients. Am Rev Respir Dis 1988; 138:110-116
15. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873
16. Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial infections and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988; 148:1161-1168
17. Constantini M, Donisi PM, Turrin MG, et al. Hospital acquired infections surveillance and control in intensive care services: Results of an incidence study. Eur J Epidemiol 1987; 3:347-355
18. De Clercq H, De Decker GH, Alexander JP, et al. Cost evaluation of infections in intensive care. Acta Anaesthesiol Belg 1983; 3:179-189
19. Wenzel RP. The mortality of hospital-acquired bloodstream infections: Need for a new vital statistic? Int J Epidemiol 1988; 17:225-227
20. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. Baltimore, MD: Williams and Wilkins, 1993; 512-555
21. Freeman J, McGowan JE Jr. Risk factors for nosocomial infection. J Infect Dis 1978; 138:811-819
22. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994; 22:55-60
23. Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia: A multivariate analysis of risk and prognosis. Chest 1988; 93:318-324
24. Gross PA, Neu HC, Aswapokee P, et al. Deaths from nosocomial infections: Experience in a university hospital and a community hospital. Am J Med 1980; 68:219-223
25. Gross PA, Van Antwerpen C. Nosocomial infections and hospital deaths: A case-control study. Am J Med 1983; 75:658-662
26. Niederman MS, Craven DE, Fein AM, et al. Pneumonia in the critically ill hospitalized patient. Chest 1990; 97:170-181
27. Rello J, Jubert P, Vallés J, et al. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996; 23:973-978
28. Craven DE, Kunches LM, Kilinsky V. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792-796
29. Freeman J, Goldmann DA, McGowan JE Jr. Methodologic issues in hospital epidemiology: IV. Risk ratios, confounding, effect modification, and the analysis of multiple variables. Rev Infect Dis 1988; 10:1118-1141
30. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient: The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-1256
31. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154:91-97
32. Kappstein I, Schulgen G, Beyer U, et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992; 11:504-508
33. Craig CP, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984; 12:233-238
34. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients: Microbiology and outcomes. Am J Respir Crit Care Med 1996; 153:343-349
35. Cunnion KM, Weber DJ, Broadhead WE, et al. Risk factors for nosocomial pneumonia: Comparing adult critical-care populations. Am J Respir Crit Care Med 1996; 153:158-162
36. Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662
37. Rello J, Rué M, Jubert P, et al. Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25:1862-1867
38. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
39. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
40. Rello J, Vallés J. Mortality as an outcome in hospital-acquired pneumonia. Infect Control Hosp Epidemiol 1998; 19:795-797
41. Brewer SC, Wunderink RG, Jones CB, et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109:1019-1029
42. Froon AHM, Bonten MJM, Gaillard CA, et al. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med 1998; 158:1026-1031
43. Kolleff MH, Wragge T, Pasque C. Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest 1995; 107:1395-1401
44. Vallés J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:179-186
45. Rello J, Ricart M, Ausina V, et al. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients: Incidence, outcome, and risk factors. Chest 1992; 102:1562-1565
46. Rello J, Vallés J, Jubert P, et al. Lower respiratory tract infections following cardiac arrest and cardiopulmonary resuscitation. Clin Infect Dis 1995; 21:310-314
47. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
48. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150:1545-1549
49. Rello J, Ausina V, Ricart M, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994; 20:193-198
50. Medeiros AA. Nosocomial outbreaks of multiresistant bacteria: Extended-spectrum beta-lactamases have arrived in North America [editorial]. Ann Intern Med 1993; 119:428-430
51. Niederman MS. Gram-negative colonization of the respiratory tract: Pathogenesis and clinical consequences. Semin Respir Infect 1990; 5:173-181
52. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Crit Care Med 1998; 157:531-539
53. Wunderink RG. Mortality and ventilator-associated pneumonia: The best antibiotics may be the least antibiotics [editorial]. Chest 1993; 104:993-995
54. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
55. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394
56. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-420
57. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study [published erratum in Am J Respir Crit Care Med 1998; 157:1005]. Am J Respir Crit Care Med 1998; 157:371-376
58. Fagon J-Y, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial. Ann Intern Med 2000; 132:621-630
59. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments. Crit Care Med 1998; 26:236-244
60. Niederman MS. Bronchoscopy for ventilator-associated pneumonia: Show me the money (outcome benefit) [editorial]! Crit Care Med 1998; 26:198-199
61. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 2000; 162:505-511
62. Ruiz M, Torres A, Ewig S, et al. Noninvasive vs invasive microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 2000; 162:119-125
63. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115
64. Rouby JJ, Martin D, Lassale E, et al. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146:1059-1066
65. Craven DE, Steger KA, Barber TW. Preventing nosocomial pneumonia: State of the art and perspectives for the 1990s. Am J Med 1991; 91:44S-53S
66. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988; 138:110-116
67. Pierson CL, Friedman BA. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units. Diagn Microbiol Infect Dis 1992; 15(suppl):19S-30S
68. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites. Am J Crit Care Med 1999; 160:608-613
69. Kollef MH. Antimicrobial therapy of ventilator-associated pneumonia [editorial]. Chest 1999; 115:8-11
70. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration. Chest 1999; 115:178-183
71. Doré P, Robert R, Grollier GJ, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Respir Crit Care Med 1996; 153:1292-1298
72. Brewer CS, Wunderink RG, Jones CB, et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1995; 108:1655-1662
73. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 1999; 29:239-244
74. Puzniak LA, Mayfield J, Leet T, et al. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001; 33:151-157
75. Niederman MS. Is "crop rotation" of antibiotics the solution to a "resistant" problem in the ICU [editorial]? Am J Respir Crit Care Med 1997; 156:1029-1031
76. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-590
77. Yates RR. New intervention strategies for reducing antibiotic resistance. Chest 1999; 115:24S-27S
78. Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:1040-1048
79. Goldman DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership. JAMA 1996; 275:234-240
80. LaForce FM. Systemic antimicrobial therapy of nosocomial pneumonia: Monotherapy vs combination therapy. Eur J Clin Microbiol Infect Dis 1989; 8:61-68
81. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87:540-546
82. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin: The Severe Pneumonia Study Group. Antimicrob Agents Chemother 1994; 38:547-557
83. Cometta A, Baumgartner JD, Lew D, et al. Prospective randomized comparison of imipenem monotherapy with imiipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 1994; 38:1309-1313
84. Sieger B, Berman SJ, Geckler RW, et al. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or respiratory tract infections with meropenem or ceftazidime with tobramycin: A randomized study. Crit Care Med 1997; 25:1663-1670
85. Niederman MS. An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am 1994; 78:1123-1141
86. Dominguez EA, Smith TL, Reed E, et al. A pilot sutdy of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol 2000: 21:S4-S8
87. Gruson D, Hilbert, G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care Med 2000; 162:837-84343